Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53
- DOI
- 10.1038/s41698-026-01563-2
- Published
- 2026-07-14
- Container
- npj Precision Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41698-026-01563-2,
title = {Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53},
author = {Yoshinori Uchihara and Keiji Tasaka and Takashi Mikami and Yosuke Yamada and Hiroaki Ito and Hajime Okita and Ryunosuke Tojo and Ryo Akazawa and Kiyotaka Isobe and Tatsuya Kamitori and Masahiko Nishitani-Isa and Hirohito Kubota and Satoshi Saida and Itaru Kato and Tatsuya Okamoto and Eri Ogawa and Hideaki Okajima and Yukichi Tanaka and Takako Yoshioka and Nobuyuki Kakiuchi and Yuichi Shiraishi and Tetsuya Takimoto and Shugo Komatsu and Mitsutaka Shiota and Kazuko Kudo and Hiroyuki Fujisaki and Masahiro Sekiguchi and Yoshiyuki Takahashi and Mamoru Ito and Tatsutoshi Nakahata and Hironori Haga and Eiso Hiyama and Seishi Ogawa and Katsutsugu Umeda and Junko Takita},
year = {2026},
journal = {npj Precision Oncology},
doi = {10.1038/s41698-026-01563-2},
url = {https://doi.org/10.1038/s41698-026-01563-2}
}RIS
TY - JOUR TI - Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53 AU - Yoshinori Uchihara AU - Keiji Tasaka AU - Takashi Mikami AU - Yosuke Yamada AU - Hiroaki Ito AU - Hajime Okita AU - Ryunosuke Tojo AU - Ryo Akazawa AU - Kiyotaka Isobe AU - Tatsuya Kamitori AU - Masahiko Nishitani-Isa AU - Hirohito Kubota AU - Satoshi Saida AU - Itaru Kato AU - Tatsuya Okamoto AU - Eri Ogawa AU - Hideaki Okajima AU - Yukichi Tanaka AU - Takako Yoshioka AU - Nobuyuki Kakiuchi AU - Yuichi Shiraishi AU - Tetsuya Takimoto AU - Shugo Komatsu AU - Mitsutaka Shiota AU - Kazuko Kudo AU - Hiroyuki Fujisaki AU - Masahiro Sekiguchi AU - Yoshiyuki Takahashi AU - Mamoru Ito AU - Tatsutoshi Nakahata AU - Hironori Haga AU - Eiso Hiyama AU - Seishi Ogawa AU - Katsutsugu Umeda AU - Junko Takita PY - 2026 JO - npj Precision Oncology DO - 10.1038/s41698-026-01563-2 UR - https://doi.org/10.1038/s41698-026-01563-2 ER -
APA
Uchihara, Y., Tasaka, K., Mikami, T., Yamada, Y., Ito, H., Okita, H., Tojo, R., Akazawa, R., Isobe, K., Kamitori, T., Nishitani-Isa, M., Kubota, H., Saida, S., Kato, I., Okamoto, T., Ogawa, E., Okajima, H., Tanaka, Y., Yoshioka, T., Kakiuchi, N., Shiraishi, Y., Takimoto, T., Komatsu, S., Shiota, M., Kudo, K., Fujisaki, H., Sekiguchi, M., Takahashi, Y., Ito, M., Nakahata, T., Haga, H., Hiyama, E., Ogawa, S., Umeda, K., & Takita, J. (2026). Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53. npj Precision Oncology. https://doi.org/10.1038/s41698-026-01563-2
Source records
- crossref · retrieved 2026-09-26T18:02:23.468Z